Dalal Street Investment Journal|June 08 - 21, 2020
Marksans Pharma manufactures and markets analgesics, expectorants as well as the anti-diabetic, cardiovascular, central nervous system, gastrointestinal and oncologic drugs in addition to antibiotic and anti-allergic products. The company also engages in research, offering contract research manufacturing services to global pharmaceutical companies. It is headquartered in Mumbai with subsidiaries across the globe. Its footprint extends across the United Kingdom, the United States, and Australia, coupled with proprietary marketing networks in these countries.
You can read up to 3 premium stories before you subscribe to Magzter GOLD
Log in, if you are already a subscriber
Get unlimited access to thousands of curated premium stories and 5,000+ magazines
READ THE ENTIRE ISSUE
June 08 - 21, 2020